WALTHAM, Mass., Sep 07, 2011 (BUSINESS WIRE) -- Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live from the Morgan Stanley Global Healthcare Conference on Wednesday, September 14, 2011, at 10:20 a.m. ET. In addition, Alkermes' corporate presentation will be webcast live from the UBS Global Life Sciences Conference on Wednesday, September 21, 2011, at 2:30 p.m. ET. Both presentations will be webcast from the Grand Hyatt Hotel in New York City. The presentations may be accessed at http://www.alkermes.com. The presentations will be archived for 14 days.
Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL® for alcohol and opioid dependence and manufactures RISPERDAL® CONSTA® for schizophrenia and bipolar I disorder. Alkermes' robust pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Waltham, Massachusetts, Alkermes has a research facility in Massachusetts and a commercial manufacturing facility in Ohio.
SOURCE: Alkermes, Inc.
Alkermes, Inc.
Eva Stroynowski, 781-609-6823
Corporate Communications